June 15, 2014
The following letter, signed by 122 public health and medical experts from 31 countries, representing every WHO region, was delivered to WHO Director General Margaret Chan earlier today. (PDF of letter)
An updated version of the letter, with 129 signatures, is here.
June 16, 2014
Dr. Margaret Chan
Director General
World Health Organization
Geneva
Dear Dr. Chan,
We, the 122 signatories to this letter, are writing to express our support for WHO’s evidence-based approach to determine the best way forward for public health to respond to Electronic Nicotine Delivery Systems (ENDS), as expressed in WHO's June 3, 2014 statement.[1]
June 15, 2014
Lauren Lempert and I just submitted this public comment to FDA. The comment number is 1jy-8cos-3k4o.
FDA Should Not Extend the Compliance Period for Marketing Applications and Other Submissions
Docket No. FDA-2014-N-0189
Lauren K. Lempert, JD, MPH and Stanton A. Glantz, PhD
Center for Tobacco Control Research and Education
University of California San Francisco
June 15, 2014
There is no rational justification for FDA’s proposal to extend the compliance period for submitting a marketing application under either the substantial equivalence (SE) pathway or the premarket tobacco application (PMTA) pathway to 24 months following the effective date of a final rule under the current rule making. The FDA should shorten the compliance periods to no more than 6 months.
Premarket authorization and the substantial equivalence loophole
June 14, 2014
FDA SHOULD NOT MAKE REGULATORY DECISIONS BASED ON THE "CONTINUUM OF RISK" THEORY UNTIL IT HAS AFFIRMATIVE EVIDENCE THAT, AS ACTUALLY USED, E-CIGARETTES OR OTHER TOBACCO PRODUCTS LOWER POPULATION RISK
Stanton A. Glantz, PhD
Professor of Medicine
University of California, San Francisco
Docket No. FDA-2014-N-0189
June 14, 2014
Stanford Professor Bonnie Halpern-Felsher just submitted this comment to FDA. The tracking number is 1jy-8cnr-xpv8.
FDA Should Restrict Internet Sales of All Tobacco Products Including E-Cigarettes
Docket No. FDA-2014-N-0189
Bonnie Halpern-Felsher, PhD, FSAHM
Division of Adolescent Medicine
Department of Pediatrics
Stanford University
June 13, 2014
June 13, 2014
The Ontario Tobacco Research Unit in Canada recently published "Exposure to Onscreen Tobacco in Movies among Ontario Youth, 2004-2013". Here is the executive summary:
Movies are a powerful vehicle for promoting tobacco and health; authorities all over the world have concluded that smoking in movies is a cause for smoking initiation and progression to regular smoking among youth. Higher exposure to onscreen tobacco increases the uptake of smoking among youth and undermines tobacco prevention efforts.